Penn Medicine

Regulatory Gaps in AI Healthcare Systems Demand Immediate Attention

Penn Medicine experts identify critical shortcomings in current FDA approval pathways for AI-enabled medical devices, calling for enhanced regulatory frameworks to address AI drift and deployment challenges.